Innovative Manufacturing Enzene Biosciences has pioneered the fully-connected continuous manufacturing platform, EnzeneX, and continuously evolves its technology with the latest FCCM™ 2.0 version, highlighting a strong commitment to cutting-edge biologics production which can be leveraged for high-quality, cost-effective biologic solutions.

Global Expansion The company recently expanded its manufacturing footprint to the United States with a new $50 million facility in Hopewell, New Jersey, creating opportunities for partners looking to access advanced biologics manufacturing capabilities in North America.

Award-Winning Excellence Receiving the 2025 CPHI Pharma Award for Manufacturing Excellence emphasizes Enzene's industry leadership and technological edge, making it a compelling partner for organizations seeking reliable, innovative biologics development and supply chain solutions.

Strategic Collaborations Enzene's recent partnership with Virtuosi and collaborations with healthcare companies like Hetero Healthcare signal strong industry ties and a growing network, opening avenues for joint ventures and co-developed biosimilars that can meet high market demand.

Market-Ready Products The launch of biosimilar Perzea, India's most affordable Pertuzumab, demonstrates Enzene's capability to develop cost-effective biosimilars, appealing to global markets seeking affordable biologic therapies and creating sales opportunities in expanding healthcare sectors.